Who We Are
We are a growing international specialist healthcare company. Our mission is to bring to market medical products that meet the needs of specialist healthcare physicians and their patients.
We are focused on three business areas: Specialty Pharmaceuticals, Interventional Medicine and Licensing & Biotechnology.
Our products include a treatment for snakebites, antidotes to treat toxicity associated with medicines used for heart conditions and cancer, and interventional oncology products that are used to treat patients with liver or prostate tumours.
We develop our own products and we in-license or acquire them from others. We sell direct to our customers in the US and elsewhere principally through partners.
In everything we do, we are guided by our core values and our Code of Conduct. We believe that by doing the right thing every time, we will deliver enduring value to all our stakeholders.
BTG at a glance
Our latest Corporate Profile provides a snapshot of us today.
Download document (PDF - 110KB)
We plan to take some of our development programmes to market ourselves and partner some others.